Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. by Sader HS, Jones RN, Gales AC, Winokur P, Kugler KC, Pfaller MA and Doern GV published in Diagn. Microbiol. Infect. Dis. 1998; 32 (4): 289-301

Multicenter evaluation of the antimicrobial activity for six broad- spectrum β-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group.

Multicenter evaluation of the antimicrobial activity for six broad- spectrum β-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group. by Pfaller MA, Jones RN and Doern GV published in Diagn. Microbiol. Infect. Dis 1998; 30 (1): 45-52

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic.

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. by Pfaller MA, Jones RN, Messer SA, Edmond MB and Wenzel RP published in Diagn. Microbiol. Infect. Dis. 1998; 30 (2): 121-129

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. by Pfaller MA, Marco F, Messer SA and Jones RN published in Diagn. Microbiol. Infect. Dis. 1998; 30 (4): 251-255

National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program.

National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. by Pfaller MA, Jones RN, Messer SA, Edmond MB and Wenzel RP published in Diagn. Microbiol. Infect. Dis. 1998; 31 (1): 327-332

Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates.

Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. by Pfaller MA, Lockhart SR, Pujol C, Swails-Wenger JA, Messer SA, Edmond MB, Jones RN, Wenzel RP and Soll DR published in J. Clin. Microbiol. 1998; 36 (6): 1518-1529

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.

International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. by Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ and Messer SA published in J. Clin. Microbiol. 1998; 36 (7): 1886-1889

Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997).

Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). by Pfaller MA, Jones RN, Doern GV and Kugler K published in Antimicrob. Agents. Chemother. 1998; 42 (7): 1762-1770

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole. by Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME and Hajjeh RA published in Antimicrob. Agents Chemother. 1998; 42 (12): 3242-3244

In vitro activity of cefepime and other broad-spectrum β-lactams tested against 129 mec A-negative Staphylococcus spp. isolates: A multicenter sample.

In vitro activity of cefepime and other broad-spectrum β-lactams tested against 129 mec A-negative Staphylococcus spp. isolates: A multicenter sample. by Marshall SA, Wilke WW, Chen YS, Pfaller MA and Jones RN published in Diagn. Microbiol. Infect. Dis. 1998; 30 (1): 65-69